FDA OKs broader use of ergo imaging system

01/31/2013 | MedGadget.com

Digirad has received FDA clearance for expanded use of its ergo imaging system. The broader clearance covers lymphatic scintigraphy and parathyroid scintigraphy for evaluation of lesions in the breast and elsewhere in the body. The device was first cleared three years ago by the FDA.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN